Abstract:Xiaoyu Wu, 1, &ast Danfei Ji, 1, &ast Zefan Wang, 1, &ast Wenhua Yu, 2 Quan Du, 2 Wei Hu, 3 Yongke Zheng, 3 Xiaoqiao Dong, 2 Fanghui Chen 4 1 The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 3 Department of Intensive Care Unit, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 4 Emergency Department, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoqiao Dong; Fanghui Chen, Email ; Background: NADPH oxidase 2 (NOX2) is highly expressed in injured brain tissues. We determined serum NOX2 levels of aneurysmal subarachnoid hemorrhage (aSAH) patients and further investigated correlation of serum NOX2 levels with disease severity, delayed cerebral ischemia (DCI) plus prognosis after aSAH. Methods: Serum NOX2 levels were measured in 123 aSAH patients and 123 healthy controls. World Federation of Neurological Surgeons scale (WFNS) score and modified Fisher (mFisher) score were utilized to assess disease severity. Modified Rankin scale (mRS) score was used to evaluate the clinical prognosis at 90 days after aSAH. Relations of serum NOX2 levels to DCI and 90-day poor prognosis (mRS score of 3– 6) were analyzed using multivariate analysis. Receiver operating characteristic curve (ROC) was built to evaluate the prognostic predictive capability. Results: Serum NOX2 levels in aSAH patients, compared with healthy controls, were significantly increased, and were independently correlated with WFNS score, mFisher score and post-stroke 90-day mRS score. Patients with poor prognosis or DCI had significantly higher serum NOX2 levels than other remainders, and serum NOX2 levels independently predicted 90-day poor prognosis and DCI. Serum NOX2 had high prognosis and DCI predictive abilities, and their areas under ROC curve were similar to those of WFNS score and mFisher score. Conclusion: Serum NOX2 levels are significantly associated with hemorrhage severity, poor 90-day prognosis and DCI in aSAH patients. Hence, complement NOX2 may serve as a potential prognostic biomarker after aSAH. Keywords: NADPH oxidase 2, biomarker, aneurysmal subarachnoid hemorrhage, disease severity, delayed cerebral ischemia, prognosis Spontaneous subarachnoid hemorrhage (SAH) is a common emergency in neurosurgical science. Aneurysmal SAH (aSAH) approximately accounts for 85% of spontaneous SAH. 1 aSAH is characterized by rapid onset, and high rates of disability and death. Delayed cerebral ischemia (DCI) is a serious complication after aSAH and can greatly increase the risk of poor prognosis in such patients. 2 Therefore, DCI prediction is of clinical benefit to aSAH management. During decades, biomarkers have been paid extensive attentions with respect to their aidance in severity assessment and prognostic prediction. The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family includes 7 subtypes of oxidases, among which NADPH oxidase 2 (NOX2) is one of its main members and is most widely distributed in the central nervous system. 3 NOX2, as one of the main pathways for the production of reactive oxygen species (ROS) clusters in brain tissue, 4 can reportedly promote inflammatory responses and oxidative stress, thereby disrupting the blood–brain barrier (BBB), exacerbating brain tissue edema and finally aggravating neuronal damage. 5–8 NOX2 expression was significantly elevated in brain tissues of mice with traumatic brain injury (TBI) and SAH. 5,9 Consistently, elevated expression of NOX2 was revealed in brain tissues from mice model of epileptic ictus or middle cerebral artery occlusion (MCAO). 10,11 Also, NOX2 expression by astrocytes was significantly higher in TBI patients than in controls. 12 Overall, it is speculated that NOX2 may represent a potential biomarker of acute brain injury. In this study, we prospectively and consecutively enrolled aSAH patients, who were admitted to Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine (Hangzhou, China) from January 2018 to March 2021. We required (1) age between 18 and 80 years; (2) admission within 24 hours after symptom onset; (3) SAH confirmed by computerized tomography (CT) scan; -Abstract Truncated-

Increased NOX2 Expression in Astrocytes Leads to Enos Uncoupling Through Dihydrofolate Reductase in Endothelial Cells after Subarachnoid Hemorrhage

Endothelial NOX4 Aggravates Enos Uncoupling by Decreasing Dihydrofolate Reductase after Subarachnoid Hemorrhage

Pathological relevance of uncoupled eNOS in ischemia-induced neurovascular injury

Role of endothelial nitric oxide synthase for early brain injury after subarachnoid hemorrhage in mice

Involvement of Nox2 and Nox4 Nadph Oxidases in Early Brain Injury after Subarachnoid Hemorrhage

Inhibiting HIF-1α by 2ME2 Ameliorates Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats

β-Amyloid Accumulation in Neurovascular Units Following Brain Embolism

Enhancing S-nitrosoglutathione Reductase Decreases S-nitrosylation of Drp1 and Reduces Neuronal Apoptosis in Experimental Subarachnoid Hemorrhage Both in Vivo and in Vitro

Cerebral nitric oxide and mitochondrial function in patients suffering aneurysmal subarachnoid hemorrhage—a translational approach

Elevated Serum NOX2 Levels Contribute to Delayed Cerebral Ischemia and a Poor Prognosis After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study

NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration

HIF-1 α mediated up-regulation of BNIP3 involving in early cortical apoptosis after subarachnoid hemorrhage

NOX2-mediated Reactive Oxygen Species Are Double-Edged Swords in Focal Cerebral Ischemia in Mice.

Targeting iNOS Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage via Promoting Ferroptosis of M1 Microglia and Reducing Neuroinflammation

Endothelial nitric oxide synthase protects neurons against ischemic injury through regulation of brain-derived neurotrophic factor expression.

Inhibition of NOX4/ROS Suppresses Neuronal and Blood-Brain Barrier Injury by Attenuating Oxidative Stress After Intracerebral Hemorrhage

Sodium/Hydrogen Exchanger 1 Participates in Early Brain Injury after Subarachnoid Hemorrhage Both in Vivo and in Vitro Via Promoting Neuronal Apoptosis

Neutrophils and Neutrophil Extracellular Traps Cause Vascular Occlusion and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Mice

Endothelial EGLN3-PKM2 signaling induces the formation of acute astrocytic barrier to alleviate immune cell infiltration after subarachnoid hemorrhage

NOD2 is Involved in the Inflammatory Response after Cerebral Ischemia-Reperfusion Injury and Triggers NADPH Oxidase 2-Derived Reactive Oxygen Species

Nrf2 activation by neferine mitigates microglial neuroinflammation after subarachnoid hemorrhage through inhibiting TAK1-NF-κB signaling